Veracyte, Inc. (VCYT)
VCYT sees surge in social media buzz, but 30-day price decline continues. Investors watch for potential shift as social dominance grows.
About Veracyte, Inc.
Veracyte, Inc. is a healthcare company specializing in AI-driven diagnostics.
Veracyte, Inc. uses the ticker $VCYT for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- Veracyte, Inc. (VCYT) social dominance is up 240% from the previous week.
- Veracyte, Inc. (VCYT) Galaxy Score™ is up 212.5% from the previous [--] months.
- Veracyte, Inc. (VCYT) posts created is up 16.67% from the previous week.
Price: $36
Price 24-Hour Time-Series Raw Data
The current price action for Veracyte, Inc. (VCYT) is primarily driven by a substantial increase in social media engagement and positive sentiment, pushing the stock towards its 52-week high, despite a recent 30-day price decline and a dip in its Galaxy Score.
24-Hour: 0.73% 7-Day: -1.91% 30-Day: -13.33%
1-Year High: $49.40 on 2025-11-25
1-Year Low: $23 on 2025-07-21
AltRank: [-----]
AltRank 24-Hour Time-Series Raw Data
Veracyte, Inc. (VCYT) is currently AltRank #1,575 based on combined combined social and market metrics
Daily Average: [-----]
[--] Week: [-----] [----]
[--] Month: [-----] +89
[--] Months: [-----] +123
[--] Year: [-----] +323
1-Year High: [-----] on 2026-01-23
1-Year Low: [--] on 2025-03-08
Galaxy Score: [-----]
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] +15
[--] Month: [--] +26
[--] Months: [--] +34
[--] Year: [--] [---]
1-Year High: [--] on 2025-11-05
1-Year Low: [--] on 2025-12-09
Engagements: [---] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [-----]
[--] Week: [-----] -68%
[--] Month: [------] +759%
[--] Months: [-------] -48%
[--] Year: [-------] +21%
1-Year High: [------] on 2025-07-11
1-Year Low: [--] on 2026-01-03
Engagements by network (24h): YouTube: [--] X: [---] Reddit: [--]
Mentions: [--] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [--] -34%
[--] Month: [--] -3.90%
[--] Months: [---] -29%
[--] Year: [-----] +47%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-10-12
Mentions by network (24h): YouTube: [--] X: [--] Reddit: [--]
Creators: [--] (24h)
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Veracyte, Inc. (VCYT) in the last [--] hours which is down 23% from [--] in the previous [--] hours
Daily Average: [--]
[--] Week: [--] -29%
[--] Month: [--] -29%
[--] Months: [---] -47%
[--] Year: [-----] +146%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-10-12
The most influential creators that mention Veracyte, Inc. in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @VulcanMK5 | [--] | [-----] | [--] | [--] |
Sentiment: 100%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 100%
Daily Average: 86%
[--] Week: 100% no change
[--] Month: 75% -25%
[--] Months: 75% -13%
[--] Year: 75% +4%
1-Year High: 100% on 2025-02-20
1-Year Low: 30% on 2025-02-26
Most Supportive Themes:
- Increased Social Media Activity: (70%) Veracyte, Inc. (VCYT) has seen a significant surge in social media engagement and mentions over the past week, indicating growing interest from the online community.
- Positive Social Dominance Trend: (20%) The social dominance of Veracyte, Inc. (VCYT) has increased, suggesting a stronger presence and influence in online discussions relative to other topics.
Most Critical Themes:
- Short-Term Price Decline Despite Social Momentum: (80%) While social media buzz is high, Veracyte, Inc. (VCYT) has experienced a recent 30-day price decline, suggesting that short-term social momentum is currently outweighing fundamental indicators.
- Dip in Galaxy Score: (20%) The Galaxy Score for Veracyte, Inc. (VCYT) has recently dipped, which may indicate a temporary decrease in its overall social and market performance metrics.
Social Dominance: 0.0009470433644391982%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.0009470433644391982%
Daily Average: 0.00426%
[--] Week: 0.00102% +0.0007200000000000002%
[--] Month: 0.0016% +0.0005%
[--] Months: 0.0016% -0.0024%
[--] Year: 0.0016% -0.004%
1-Year High: 0.031% on 2025-06-28
1-Year Low: 0.0001% on 2025-10-12
Market Dominance: 0.00323%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00323%
Daily Average: 0%
1-Year High: 0.132% on 2026-02-06
1-Year Low: 0.00323% on 2026-02-17
Market Cap: $2,848,141,703
Market Cap 24-Hour Time-Series Raw Data
Current Value: $2,848,141,703
Daily Average: $2,646,248,243
[--] Week: $2,848,141,703 -2.70%
[--] Month: $2,848,141,703 -13%
[--] Months: $2,848,141,703 +23%
[--] Year: $2,848,141,703 -12%
1-Year High: $3,903,448,163 on 2025-11-25
1-Year Low: $1,803,585,491 on 2025-07-21
Top Veracyte, Inc. Social Posts
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"Can molecular subtypes refine risk beyond traditional staging Dr. Carissa Chu discusses how molecular subtypes capture biologic heterogeneity offering additional context for risk stratification and patient counseling in bladder cancer. Watch the full episode here: This content is sponsored by Veracyte. #URO280 #UrologicOncology #BladderCancer #Biomarkers #GenomicClassifiers #PrecisionMedicine https://www.youtube.com/watchv=i_l5EkpQRTY https://www.youtube.com/watchv=i_l5EkpQRTY"
X Link @_backtableUro 2026-02-16T10:00Z [----] followers, [----] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing